Nivolumab plus Cabozantinib versus Sunitinib for Advanced Renal-Cell Carcinoma

Published 2021 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
Nivolumab plus Cabozantinib versus Sunitinib for Advanced Renal-Cell Carcinoma
Authors
Keywords
-
Journal
NEW ENGLAND JOURNAL OF MEDICINE
Volume 384, Issue 9, Pages 829-841
Publisher
Massachusetts Medical Society
Online
2021-03-04
DOI
10.1056/nejmoa2026982

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.